In 6 months of intervention with a supplemental dose of 2 g/day of omega-3 in women with PCOS, they showed a reduction in total cholesterol, LDL, and triglycerides and a significant increase in HDL cholesterol
That is why Im encouraged by the research I led that shows people with breast cancer did in fact lose weight while taking GLP-1 medications, when we would generally expect them to gain unwanted weight related to breast cancer treatment
The design and development of deferiprone (L1) and other iron chelators for clinical use: targeting methods and application prospects
Tsioufis K, Biomolecules (Vol 15, Issue 6, June 2025, Article 796)
Pharmacies that ship the same way in January and July are not adequately protecting your medication
In this article, well break down the latest evidence, side effect profiles, and long-term considerations to help you make an informed decision on GLP-1 therapy